The page is the record's research on the issuer — no analyst, no rating, no view.

# Alto Neuroscience, Inc. (NYSE: ANRO) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The record holds Alto Neuroscience, Inc., listed on the NYSE under ticker ANRO, with ISIN US02157Q1094. The LEI is not on the record: no GLEIF record with the exact legal name in jurisdiction US-DE was found. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.

## The disclosure read

The record holds 65 filings across 32 filing days in the twelve months to 2026-11-08. The median gap between filing days is 7 days, and the median latency from the latest filing to the record date is 9 days. The NYSE medians are a cadence gap of 6.0 days and 64.0 filings across 3256 issuers, with latency of 4.0 days. The 2834 Pharmaceutical Preparations sector medians are a cadence gap of 6.0 days and 63.0 filings across 526 issuers, with latency of 4.0 days. The latest filing is dated 2026-10-30 and is of type regulatory filing.

## Auditor

The auditor of record is Deloitte & Touche LLP, located in Chicago, Illinois. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

## Open research

No openly published research notes were found. The count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The issuer is held in sealed years 2023, 2024, 2025 and 2026. The market's vintage is sealed, with the earliest sealed date at 2021-01-04. The live record began on 2026-09-12.

## Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001999480.json (identity.jurisdiction)
- https://mcp.us-cm-kg.ai/events/NYSE/ANRO (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1999480/000199948026000002/alto-20251231.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NYSE/ANRO (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/ANRO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
